Answers are grounded in this paper and cite their sources.
Massively parallel sequencing (MPS) is now a clinical reality, promising improved diagnosis, targeted therapies, and population-based screening. To realize the potential of genomics, we must learn how to apply this technology optimally. The NCGENES project is designed to address several challenges that must be overcome in order to integrate MPS into clinical care.
No takes yet. Share an insight, caveat, or question.
Foreman et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: